Not surprisingly, tumor cells develop mechanisms to escape the innate immune surveillance and these strategies include the release of soluble NKG2D-L to render target cells invisible for an NKG2D-dependent NK cell-attack. This evidence concerns the gene KLRK1 and neoplasm.